What is the Impact Factor of Liver Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Liver Cancer is 10.5, ranking in quartile Q1 of Web of Science (SCIE).

Is Liver Cancer indexed in Web of Science or Scopus?

Yes, Liver Cancer is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 3.334 (Q1) and an H-index of 69.

Who publishes Liver Cancer and what is the Article Processing Charge (APC)?

Liver Cancer is published by S. Karger AG. The estimated Article Processing Charge (APC) is approximately $4,063 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Liver Cancer?

The official ISO-4 abbreviation of Liver Cancer is "LIVER CANCER". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #602Top JournalGold OA

Liver Cancer

Abbreviation (ISO):LIVER CANCER

•

Identifier (ISSN):2235-1795(Print)/1664-5553(Online)

•

Publisher:S. Karger AG

Official Website Submission Portal Compare

Clarivate IF (2026)

10.5↑ +1.4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Liver Cancer

WoS Q1

Annual Impact Factor Metric

Current (2026):10.5

Scopus SJR & RankScopus Q1

3.334

#602

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

69 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate7.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

50articles/year

100% Gold OA•80.77% Original Research

Aims & Scope

Liver cancer has a very high prevalence among cancers in general and is one of the most common causes of death worldwide. Based on these facts, the journal ‘Liver Cancer’ serves the growing need to better understand the causes, mechanisms and therapy of the malignancy. It provides the international community of researchers and clinicians with a platform for their research results, focusing on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy, of the disease. 'Liver Cancer' publishes clinical and translational research related to the field of liver cancer in both humans and experimental models in the form of original and review articles.

Topics Covered (Recognized by AI)

Medicine98%Internal medicine66.8%Biology66.6%Genetics64.6%Cancer research61.5%Hepatocellular carcinoma60.4%Pathology40.1%Surgery38.4%Oncology33.8%Cancer32.8%Gastroenterology32.6%Radiology20.8%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

GASTROENTEROLOGY & HEPATOLOGY

Rank11/153

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank36/333

IndexSCIE

JCISCIE2026

GASTROENTEROLOGY & HEPATOLOGY

Rank13/153

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank34/333

IndexSCIE

Category	Index	Rank	Quartile
GASTROENTEROLOGY & HEPATOLOGY	JCRSCIE	11/153	Q1
ONCOLOGY	JCRSCIE	36/333	Q1
GASTROENTEROLOGY & HEPATOLOGY	JCISCIE	13/153	Q1
ONCOLOGY	JCISCIE	34/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF10.5

Articles / Year59

Total Citations35

2025

IF9.1

Articles / Year84

Total Citations402

2024

IF11.6

Articles / Year60

Total Citations611

2023

IF13.8

Articles / Year68

Total Citations1,771

2022

IF12.43

Articles / Year77

Total Citations1,818

Year	Impact Factor	Articles / Year	Total Citations
2026	10.5	59	35
2025	9.1	84	402
2024	11.6	60	611
2023	13.8	68	1,771
2022	12.43	77	1,818
2021	11.74	99	4,251
2020	9.72	62	3,229
2019	5.944	65	2,028
2018	0	72	3,104
2017	—	42	1,723
2016	—	47	2,128
2015	—	36	2,165

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #602Scopus Q1SCImago Profile

Scopus Coverage:2009, 2012-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

3.334

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

8.92

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,063 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,645

3-Year Documents182

Citable Documents148

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate29.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HepatologyQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 7.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

2区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Liver Cancer (abbr: LIVER CANCER, ISSN: 2235-1795) is a peer-reviewed international scholarly journal in the field of Medicine, published by S. Karger AG in Switzerland. The periodical holds a Journal Impact Factor (JIF) of 10.5, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.334 (Q1), an H-index of 69.

The journal enforces rigorous peer evaluation with an annual output of approximately 50 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,063 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.